시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 볼프 파킨슨 화이트(WPW) 증후군 시장 보고서(2025년)
Wolff Parkinson White Syndrome Global Market Report 2025
상품코드 : 1821659
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

볼프 파킨슨 화이트(WPW) 증후군 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.1%로 14억 7,000만 달러로 성장할 것입니다. 예측 기간의 성장은 인식 개선 및 스크리닝 프로그램, 전기생리학적 개입의 혁신, 정밀의료 및 유전자 연구, 환자 중심의 치료 접근법, 전문 의료에 대한 접근성 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 첨단 진단 기술, 전기생리학적 개입의 발전, 맞춤형 치료 접근법, 원격의료, 원격 모니터링 등이 있습니다.

향후 5년간 5.1%의 성장률 전망은 지난번 예측보다 0.3% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 이스라엘과 네덜란드에서 개발된 3D 심장 매핑 시스템 및 절제용 카테터 가격을 급등시켜 부정맥 치료 지연과 전기생리검사실 비용 증가를 초래하는 등 미국의 심장 치료에 지장을 초래할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

유전성 질환의 발견 건수 증가가 예상됨에 따라 볼프 파킨슨 화이트(WPW) 증후군 시장의 성장이 예상됩니다. 유전성 질환은 단일 유전자 돌연변이, 다중 유전자 돌연변이, 유전자 돌연변이와 환경적 영향의 조합, 또는 염색체 손상으로 인해 발생할 수 있습니다. 유전성 질환의 확인이 증가하면 볼프 파킨슨 화이트(WPW) 증후군의 검사 및 치료 수요가 증가합니다. 예를 들어, 2023년 6월 영국 의학잡지 랜싯(Lancet)이 발표한 보고서에 따르면, 겸상 적혈구증 세계 인구가 41.4% 급증해 2021년에는 774만 명에 달할 것으로 나타났습니다. 이러한 급격한 증가는 34,400명의 원인별 사망을 초래하고, 37만 6,000명의 총 사망자 부담을 크게 증가시킬 것으로 예측됩니다. 5세 미만 소아에서는 2023년 8만 1,100명이 사망할 것으로 예상되며, 전체 겸상 적혈구증 사망률은 세계 12위를 차지할 것으로 예상됩니다. 이처럼 유전성 질환의 발견이 증가하면서 볼프 파킨슨 화이트(WPW) 증후군 시장의 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Wolff-Parkinson's syndrome is characterized by an accelerated pulse caused by an additional electrical pathway connecting the heart's upper and lower chambers, leading to Wolff-Parkinson-White (WPW) syndrome and resulting in rapid heartbeat or tachycardia with a narrow electrocardiographic complex (QRS). Effective management involves two main types of treatments, namely Type A and Type B. Type A treatment is specifically designed for Type A WPW syndrome, identified by an upright positive delta wave and higher R than S amplitude in lead V1.08.

The diagnostic process for Wolff-Parkinson-White syndrome includes an electrocardiogram (ECG), electrophysiological testing, and other relevant assessments. Various treatment modalities, such as medications, cardioversion, radiofrequency catheter ablation, surgery, and artificial pacemakers, are employed in diverse healthcare settings, including hospitals, clinics, academic and research institutions, and by other end-users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The Wolff Parkinson White Syndrome market research report is one of a series of new reports from The Business Research Company that provides Wolff Parkinson White Syndrome market statistics, including Wolff Parkinson White Syndrome industry global market size, regional shares, competitors with a Wolff Parkinson White Syndrome market share, detailed Wolff Parkinson White Syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the Wolff Parkinson White Syndrome industry. This Wolff-Parkinson-White Syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wolff parkinson white syndrome market size has grown steadily in recent years. It will grow from $1.17 billion in 2024 to $1.21 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to market expansion and accessibility, holistic care models, research funding and initiatives, advances in minimally invasive procedures, patient education and advocacy.

The wolff parkinson white syndrome market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rise in awareness and screening programs, innovations in electrophysiology interventions, precision medicine and genetic research, patient-centric care approaches, increased access to specialized care. Major trends in the forecast period include advanced diagnostic technologies, advancements in electrophysiology intervention, personalized treatment approaches, telemedicine and remote monitoring.

The forecast of 5.1% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. cardiac care by inflating prices of 3D cardiac mapping systems and ablation catheters developed in Israel and the Netherlands, resulting in delayed arrhythmia treatments and higher electrophysiology lab expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the detection of genetic diseases is expected to drive the growth of the Wolff Parkinson's White syndrome market. Genetic disorders can arise from a single gene mutation, multiple gene mutations, a combination of gene mutations and environmental influences, or chromosomal damage. An increase in the identification of genetic diseases will heighten the demand for testing and treatment of Wolff Parkinson White syndrome. For example, in June 2023, a report published by The Lancet, a UK-based medical journal, revealed that the global population of individuals with sickle cell disease surged by 41.4%, reaching 7.74 million in 2021. This surge is projected to lead to 34,400 cause-specific deaths and a considerably higher total mortality burden of 376,000. Among children under five years old, there were 81,100 deaths in 2023, raising the overall sickle cell disease mortality ranking to 12th globally. Thus, the increase in the detection of genetic diseases is propelling the growth of the Wolff Parkinson White syndrome market.

Government investments in healthcare are expected to drive the growth of the Wolff-Parkinson-White syndrome market. The healthcare sector has experienced a significant influx of investment, innovation, and new participants from the technology, communications, and consumer goods industries. These investments bolster the market for Wolff-Parkinson-White syndrome. For instance, in May 2023, the Office for National Statistics, a government agency in Wales, reported that total healthcare spending in 2022 was approximately 26.8% ($78 billion) (£60 billion) higher in nominal terms and 13.5% ($41 billion) (£32 billion) higher in real terms compared to levels prior to the coronavirus pandemic. Therefore, government investments in healthcare are fueling the growth of the Wolff-Parkinson-White syndrome market.

Technological innovation is a significant trend gaining traction in the Wolff-Parkinson-White syndrome market. Leading companies in this sector are advancing their technologies and investing in research and development to secure a competitive advantage. For instance, in May 2023, Abbott, a U.S.-based healthcare company, announced that its TactiFlex Ablation Catheter, Sensor Enabled received approval from the U.S. Food and Drug Administration (FDA). This catheter is designed to create focal lesions during cardiac ablation procedures, which helps block abnormal electrical signals that lead to arrhythmias. It is specifically indicated for patients with paroxysmal atrial fibrillation, where episodes last less than seven days and are not effectively managed with medication, and can also be used for type I atrial flutter.

Major companies in the Wolff-Parkinson-White syndrome market are innovating advanced machines and devices, such as minimally invasive procedure devices, to provide improved treatment options and solutions. A minimally invasive procedure device is a medical device designed to perform surgical procedures with minimal damage to the body's tissues. For example, in May 2024, Biosense Webster Inc., a U.S.-based company specializing in the diagnosis and treatment of cardiac arrhythmias, launched the CARTO 3 System Version 8. This system generates real-time, three-dimensional maps of the heart's electrical activity, assisting electrophysiologists in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation (AFib). It enhances catheter navigation within the heart, pinpointing the exact locations necessary for effective treatment during ablation procedures. Notably, the system features the CARTO ELEVATE Module, which includes the Optrell Mapping Catheter that improves signal quality and enables localized unipolar signals, thereby enhancing the accuracy of activation maps.

In a significant development during October 2023, AbbVie, a US-based pharmaceutical company, completed the acquisition of Mitokinin for an undisclosed sum. This strategic acquisition focuses on Mitokinin's lead compound, designed to target mitochondrial dysfunction, a significant contributing factor believed to influence the pathogenesis and progression of Parkinson's disease (PD). Mitokinin, a US-based discovery-stage biotechnology company, is devoted to developing a potentially pioneering disease-modifying treatment for Parkinson's Disease (PD). This acquisition strategically aligns with AbbVie's objective of enhancing its portfolio and research in addressing critical medical needs within the realm of Parkinson's Disease.

Major companies operating in the wolff parkinson white syndrome market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AngioDynamics, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Terumo Corporation, B. Braun Melsungen AG, Translumina GmbH, AtriCure Inc., CardioFocus Inc., Catheter Precision Inc., CryoLife Inc., Edwards Lifesciences Corporation, Imricor Medical Systems Inc., Johnson & Johnson Inc., Lepu Medical Technology (Beijing) Co. Ltd., Osypka AG, Koninklijke Philips N.V., Abiomed Inc.

North America was the largest region in the wolff parkinson white syndrome market share in 2024. The regions covered in the wolff parkinson white syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the wolff parkinson white syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The Wolff Parkinson's white syndrome market includes revenues earned by entities by providing various treatments such as radiofrequency ablation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wolff Parkinson White Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wolff parkinson white syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for wolff parkinson white syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wolff parkinson white syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Wolff Parkinson White Syndrome Market Characteristics

3. Wolff Parkinson White Syndrome Market Trends And Strategies

4. Wolff Parkinson White Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Wolff Parkinson White Syndrome Growth Analysis And Strategic Analysis Framework

6. Wolff Parkinson White Syndrome Market Segmentation

7. Wolff Parkinson White Syndrome Market Regional And Country Analysis

8. Asia-Pacific Wolff Parkinson White Syndrome Market

9. China Wolff Parkinson White Syndrome Market

10. India Wolff Parkinson White Syndrome Market

11. Japan Wolff Parkinson White Syndrome Market

12. Australia Wolff Parkinson White Syndrome Market

13. Indonesia Wolff Parkinson White Syndrome Market

14. South Korea Wolff Parkinson White Syndrome Market

15. Western Europe Wolff Parkinson White Syndrome Market

16. UK Wolff Parkinson White Syndrome Market

17. Germany Wolff Parkinson White Syndrome Market

18. France Wolff Parkinson White Syndrome Market

19. Italy Wolff Parkinson White Syndrome Market

20. Spain Wolff Parkinson White Syndrome Market

21. Eastern Europe Wolff Parkinson White Syndrome Market

22. Russia Wolff Parkinson White Syndrome Market

23. North America Wolff Parkinson White Syndrome Market

24. USA Wolff Parkinson White Syndrome Market

25. Canada Wolff Parkinson White Syndrome Market

26. South America Wolff Parkinson White Syndrome Market

27. Brazil Wolff Parkinson White Syndrome Market

28. Middle East Wolff Parkinson White Syndrome Market

29. Africa Wolff Parkinson White Syndrome Market

30. Wolff Parkinson White Syndrome Market Competitive Landscape And Company Profiles

31. Wolff Parkinson White Syndrome Market Other Major And Innovative Companies

32. Global Wolff Parkinson White Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wolff Parkinson White Syndrome Market

34. Recent Developments In The Wolff Parkinson White Syndrome Market

35. Wolff Parkinson White Syndrome Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기